These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 10305448)
1. Name, dosage form and strength. Davis NM Hosp Pharm; 1977 Sep; 12(9):400. PubMed ID: 10305448 [No Abstract] [Full Text] [Related]
2. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
3. Lithium carbonate and the drug lag. Clymer HA J Pharm Sci; 1977 Dec; 66(12):IV. PubMed ID: 925924 [No Abstract] [Full Text] [Related]
5. Dosage form and the physiologic availability of drugs. Middleton EJ Med Times; 1967 Apr; 95(4):385-90. PubMed ID: 6021603 [No Abstract] [Full Text] [Related]
6. Indexable imprinting of solid dosage forms. Collier WA Drug Intell Clin Pharm; 1977 Mar; 11(3):170-5. PubMed ID: 10235794 [No Abstract] [Full Text] [Related]
7. Lack of pediatric drug formulations. Nahata MC Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800 [TBL] [Abstract][Full Text] [Related]
8. Dosing botanical medicines. Yarnell E J Herb Pharmacother; 2005; 5(1):73-8. PubMed ID: 16093237 [No Abstract] [Full Text] [Related]
9. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate. Dorfman HL; Quinn VM; Brophy EA Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765 [No Abstract] [Full Text] [Related]
10. Excipients and additives. Shear NH; Dupuis LL; Zimmerman B Can Med Assoc J; 1985 Jul; 133(2):93. PubMed ID: 4005766 [No Abstract] [Full Text] [Related]
11. Remarks by the Commissioner of Food and Drugs. Kessler DA Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001 [No Abstract] [Full Text] [Related]
12. "Safer, but not safe enough". Crombie HD Conn Med; 2006; 70(10):645. PubMed ID: 17190395 [No Abstract] [Full Text] [Related]
13. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
14. FDA's regulation of prescription drug labeling: a role for implied preemption. Kendrick LC Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031 [No Abstract] [Full Text] [Related]
15. Pros and cons of off-label promotion investigations and prosecutions. Loucks MK Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041 [No Abstract] [Full Text] [Related]
16. A strike against preemption. Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422 [TBL] [Abstract][Full Text] [Related]
17. Physician may be liable for failure to heed drug insert warning. Anesth Analg; 1972; 51(2):217-9. PubMed ID: 5062122 [No Abstract] [Full Text] [Related]
18. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
19. Pediatric efficacy supplement for Videx EC. AIDS Patient Care STDS; 2008 Nov; 22(11):919. PubMed ID: 19043843 [No Abstract] [Full Text] [Related]